Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells
- PMID: 9425251
- DOI: 10.1007/s002849900290
Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells
Abstract
The ID50 values for azithromycin and clarithromycin inhibition of translation and of 50S assembly in Staphylococcus aureus cells have been measured. For clarithromycin, 50% inhibition of growth occurred at 0.075 microg/ml, and the effects on translation and 50S formation were equivalent at 0.15 microg/ml. The inhibition of these processes by azithromycin was less effective, with an ID50 of 2.5 microg/ml for growth and 5 microg/ml for inhibition of translation and 50S formation. The additive effects of each of these drugs on translation and 50S formation account quantitatively for their observed influence on cellular growth rates. In macrolide-treated cells, there was also a direct relationship between the loss of ribosomal RNA from the 50S subunit and its accumulation as oligoribonucleotides. These results are compared with the previously described effects of erythromycin on these same processes.
Similar articles
-
Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells.Microb Drug Resist. 1998 Fall;4(3):169-74. doi: 10.1089/mdr.1998.4.169. Microb Drug Resist. 1998. PMID: 9818968
-
50S ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus.Antimicrob Agents Chemother. 1996 May;40(5):1301-3. doi: 10.1128/AAC.40.5.1301. Antimicrob Agents Chemother. 1996. PMID: 8723490 Free PMC article.
-
Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells.Antimicrob Agents Chemother. 1999 Jun;43(6):1324-8. doi: 10.1128/AAC.43.6.1324. Antimicrob Agents Chemother. 1999. PMID: 10348746 Free PMC article.
-
Bacterial ribosomal subunit synthesis: a novel antibiotic target.Curr Drug Targets Infect Disord. 2001 May;1(1):19-36. doi: 10.2174/1568005013343281. Curr Drug Targets Infect Disord. 2001. PMID: 12455231 Review.
-
Azithromycin and clarithromycin: overview and comparison with erythromycin.Infect Control Hosp Epidemiol. 1992 Jun;13(6):357-68. doi: 10.1086/646545. Infect Control Hosp Epidemiol. 1992. PMID: 1320067 Review.
Cited by
-
Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat.Mol Vis. 2017 Dec 11;23:911-921. eCollection 2017. Mol Vis. 2017. PMID: 29296071 Free PMC article.
-
Antibiotics targeting bacterial ribosomal subunit biogenesis.J Antimicrob Chemother. 2020 Apr 1;75(4):787-806. doi: 10.1093/jac/dkz544. J Antimicrob Chemother. 2020. PMID: 31942624 Free PMC article. Review.
-
Unveiling the Intricacies of Monoamine Oxidase-A (MAO-A) Inhibition in Colorectal Cancer: Computational Systems Biology, Expression Patterns, and the Anticancer Therapeutic Potential.ACS Omega. 2024 Aug 9;9(33):35703-35717. doi: 10.1021/acsomega.4c04100. eCollection 2024 Aug 20. ACS Omega. 2024. PMID: 39184489 Free PMC article.
-
Influential predictors of azithromycin pharmacokinetics: a systematic review of population pharmacokinetics.Ann Med. 2025 Dec;57(1):2496792. doi: 10.1080/07853890.2025.2496792. Epub 2025 May 15. Ann Med. 2025. PMID: 40372973 Free PMC article.
-
Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques.Clin Infect Dis. 2022 Oct 17;75(Suppl 3):S411-S416. doi: 10.1093/cid/ciac569. Clin Infect Dis. 2022. PMID: 36251550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical